Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Mylan Inc       US6285301072

 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Financials ($)
Sales 2015 9 688 M
EBIT 2015 2 638 M
Net income 2015 2 090 M
Debt 2015 7 187 M
Yield 2015 -
Sales 2016 10 328 M
EBIT 2016 3 204 M
Net income 2016 2 442 M
Debt 2016 5 510 M
Yield 2016 -
PER 2015 25,74
PER 2016 17,93
EV / Sales 2015 4,27x
EV / Sales 2016 3,84x
Capitalization 34 136 M
More Financials
Company
Mylan N.V., is a pharmaceutical company which develops, licenses, manufactures, markets and distributes generic, branded generic and specialty pharmaceutical products.It operates through the following businesses: Generic Products, Rx Products, Active Pharmaceutical Ingredients, and Access... 
Sector
Pharmaceuticals
Calendar
05/28 | 04:00pmPresentation
More about the company
Surperformance© ratings of Mylan Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on MYLAN INC
05/21DJLaw Firm Advising Teva Dismisses Mylan Objections
05/21DJLaw Firm Advising Teva on Bid Dismisses Mylan's Objections to Its Involvement
05/18 Endo pushes further into generics with $8 billion Par Pharma buy
05/12 MYLAN NV : to Present at the UBS Global Healthcare Conference
05/12DJPerrigo to Buy Patheon's Mexican Business
05/12DJPerrigo to Buy Patheon's Mexican Business for $34 Million
05/12 MYLAN NV : to Present at the Bank of America Merrill Lynch Health Care Conferenc..
05/08 EXCLUSIVE : Mylan chairman tells investors he would consider buying Teva
More news
Sector news : Pharmaceuticals - NEC
05/23 GERMANY'S MERCK EXPECTS DRUG DIVISIO : Euro am Sonntag
05/22DJAmgen Ends Psoriasis-Drug Partnership With AstraZeneca -- Update
05/22 AMGEN : ends work on experimental psoriasis drug
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
03/02 Mylan (MYL) Heather M. Bresch on Q4 2014 Results - Earnings Call Transcript
03/02 Mylan Q4 revenues up 15%, Specialty up 38%
03/02 Mylan (MYL) Q4 2014 Results - Earnings Call Webcast
03/02 Mylan EPS in-line, beats on revenue
03/01 Notable earnings after Monday?s close
Comments 
Advertisement
Chart MYLAN INC
Duration : Period :
Mylan Inc Technical Analysis Chart | US6285301072 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions